FAF
ONC

Fjarde Ap-fonden’s BeOne Medicines Ltd ONC Stock Holding History

Fjarde Ap-fonden’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-5,600
Closed -$1.6M – 608
2020
Q3 		$1.6M Hold
5,600
– – 0.02% 569
2020
Q2 		$1.05M Buy
5,600
+800
+17% +$130K 0.01% 584
2020
Q1 		$591K Hold
4,800
– – 0.01% 604
2019
Q4 		$796K Buy
4,800
+600
+14% +$99.7K 0.01% 610
2019
Q3 		$514K Buy
4,200
+300
+8% +$39.8K 0.01% 603
2019
Q2 		$483K Hold
3,900
– – 0.01% 609
2019
Q1 		$515K Buy
3,900
+300
+8% +$40.5K 0.01% 591
2018
Q4 		$505K Buy
+3,600
New +$477K 0.01% 585

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Fjarde Ap-fonden's ONC Position: Q4 2020 in Review

Fjarde Ap-fonden sold out of BeOne Medicines Ltd (ONC) in Q4 2020, closing a stake of 5,600 shares — an estimated $1.6M sold.

Fjarde Ap-fonden first reported a position in ONC in Q4 2018 and held it in 8 quarters. The position peaked at $1.6M in Q3 2020. 248 funds tracked by Wall St. Rank hold ONC as of Q4 2020.

  • Fjarde Ap-fonden reported no remaining BeOne Medicines Ltd position as of Q4 2020 after selling out during the quarter.
  • Fjarde Ap-fonden sold 5,600 BeOne Medicines Ltd shares in Q4 2020, an estimated $1.6M.
  • Fjarde Ap-fonden first reported a position in BeOne Medicines Ltd in Q4 2018 and held it in 8 quarters.
  • Fjarde Ap-fonden's BeOne Medicines Ltd position peaked at $1.6M in Q3 2020.
  • 248 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2020.

Based on Fjarde Ap-fonden's 13F filing for Q4 2020, filed 12 Feb 2021.